Clinical Center of Serbia; Clinic of Urology

Belgrade 11000

0 studies enrolling now · 6 studies all time

What they study most

Bladder Cancer, Cancer of the Prostate, Carcinoma, Transitional Cell, Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer, Urinary Tract Infections, Urothelial Carcinoma, Urothelial Carcinoma Bladder

Studies at this site

• A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Running, not enrolling
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Stopped early
• A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection — Stopped early
• A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] — Completed
• A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection — Completed